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Background: The diagnosis of centrally located intrapulmonary tu-
mors not visible on bronchoscopy may be a challenge. Endobronchial
ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has
been shown to be useful for the evaluation of mediastinal lymph nodes.
However, there have been no reports of the utility of EBUS-TBNA for
the diagnosis of intrapulmonary tumors.
Objectives: The purpose of this study was to evaluate the usefulness
of EBUS-TBNA for the diagnosis of intrapulmonary tumors located
adjacent to the central airway.
Methods: From December 2002 to June 2007, 35 patients with
pulmonary masses located close to the central airways were accessed by
EBUS-TBNA. Conventional bronchoscopic biopsy before EBUS-
TBNA was nondiagnostic in 25 of the 35 cases. Patients with endo-
bronchial lesions were excluded from this study.
Results: EBUS-TBNA was performed in 19 peritracheal and 16
peribronchial lesions. Cytologic and/or histologic samples were
diagnostic in 33 of 35 patients. The final diagnoses of the pulmonary
masses were lung cancer in 26 cases (1 small cell lung cancer, 25
non-small cell lung cancer), metastatic lung tumors in 5, and BALT
lymphoma in one. The sensitivity and the diagnostic accuracy of
EBUS-TBNA for the diagnosis of unknown pulmonary masses was
94.1% and 94.3%, respectively.
Conclusions: Intrapulmonary lesions not assessable by conventional
bronchoscopic procedures can easily be assessed and diagnosed by
EBUS-TBNA as long as it is within the reach of the EBUS-TBNA
scope. EBUS-TBNA is a real-time procedure with a high yield which
can be applied for the diagnosis of lung tumors.
Key Words: Endobronchial ultrasound guided transbronchial nee-
dle aspiration, Unknown pulmonary mass, Transbronchial biopsy,
Non-small cell lung cancer.
(J Thorac Oncol. 2008;3: 985–988)
Although bronchoscopy is widely used for the diagnosis ofperipheral pulmonary masses, there are limitations in the
yield of conventional bronchoscopic modalities. To improve
the diagnostic yield of bronchoscopic biopsies, new modali-
ties have been applied such as computed tomography (CT)
guided bronchoscopy,1 virtual bronchoscopic navigation,2,3
electromagnetic navigation bronchoscopy,4,5 endobronchial
ultrasound with guide sheath (EBUS-GS),6,7 and a combination
of the different techniques.8,9 However, due to the anatomy,
lesion located in certain areas may be difficult to assess with the
present modalities. Endobronchial ultrasound-guided transbron-
chial needle aspiration (EBUS-TBNA) is a minimally invasive
procedure performed under local anesthesia that has enabled
mediastinal and hilar lymph node assessment with a high sen-
sitivity.10–14 In addition to mediastinal and hilar lymph nodes,
EBUS-TBNA can assess peritracheal and peribronchial lesions
as long as it is within the reach of the EBUS-TBNA scope.15
Herein, we describe the use of EBUS-TBNA in patients with
intrapulmonary lesions located adjacent to the central airway.
PATIENTS AND METHODS
Patients
A retrospective chart review of the EBUS-TBNA data
base of the Department of Thoracic Surgery, Chiba University
was performed to evaluate the yield of EBUS-TBNA in the
diagnosis of intrapulmonary lesions. From December 2002 to
June 2007, thirty-five patients with intrapulmonary tumors were
accessed by EBUS-TBNA. All patients were evaluated by chest
CT with contrast single injection and multidetector row CT
(Light Speed, GE Medical System, Milwaukee, WI) before the
procedure. Pulmonary masses whose drainage bronchus is dif-
ficult to be reached such as mediastinal type lung cancer adja-
cent to the trachea, lesions adjacent to the main bronchus or the
segmental bronchus were assessed by EBUS-TBNA. All pa-
tients were referred from other centers after a negative conven-
tional bronchoscopic examination or if they were deemed diffi-
cult to assess by conventional bronchoscopic methods. Patients
with endobronchial findings before EBUS-TBNA were ex-
cluded from this study.
EBUS-TBNA
EBUS-TBNAwas performed on an outpatient basis under
conscious sedation. Local anesthesia was achieved with nebu-
lised 1% lidocaine solution (5 ml) in the pharynx. A bolus dose
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of 2 ml of 2% lidocaine was used during the procedure. The
bronchoscope was inserted orally with conscious sedation by
midazolam. Patients were monitored for Electrocardiogram,
pulse oximetry, and blood pressure without the presence of
an anesthesiologist. The convex probe-EBUS (CP-EBUS)
(BF-UC260F-OL8, Olympus, Tokyo, Japan) was used for
EBUS-TBNA. The outer diameter of the linear probe is 6.9 mm
and the diameter of the bronchoscope is 6.2 mm. The size of the
tip of the bronchoscope limits the reach of the CP-EBUS to the
segmental bronchus. The CP-EBUS is integrated with a convex
transducer (7.5 MHz) which scans parallel to the insertion
direction of the bronchoscope. Images can be obtained by
directly contacting the probe or by attaching a balloon on the tip
and inflating with saline. The ultrasound image is processed in a
dedicated ultrasound scanner (EU-C2000, Olympus, Tokyo,
Japan) and is visualized along with the conventional bronchos-
copy image on the same monitor. The Power Doppler mode is
also available in this system. The dedicated 22-gauge needle
(NA-201SX-4022, Olympus, Tokyo, Japan) is used for EBUS-
TBNA. The needle is equipped with an internal sheath which is
withdrawn after passing the bronchial wall, avoiding contami-
nation during EBUS-TBNA. The needle can be visualized
through the optics and on the ultrasound image (Figure 1).
For optimal sampling, the internal sheath is used to clear
the tip of the internal lumen clogged with bronchial membrane
once the needle is inside the lesion. The internal sheath is
removed and negative pressure is applied by a syringe. The
needle is moved back and forth inside the tumor. Finally, the
needle is retrieved and the internal sheath is used once again to
push out the histologic core. The rest of the aspirated material is
smeared onto glass slides. Smears are air dried and immediately
stained by Diff-Quik staining for rapid on-site cytology to
confirm adequate cell material. Furthermore, Papanicolaou staining
and light microscopy is carried out by an independent cytopatholo-
gist. Histologic cores are fixed with formalin and stained with
hematoxylin and eosin (Figure 1). In some cases, immunohisto-
chemistry was performed for additional information. EBUS-TBNA
diagnosis was confirmed either by open thoracotomy, thoracoscopy
or clinical follow-up for at least 6 months.
Data Analysis
The sensitivity, specificity, positive predictive value,
negative predictive value, and diagnostic accuracy rate was
calculated using the standard definitions.
RESULTS
Patient Characteristics
Thirty-five patients with intrapulmonary lesions adja-
cent to the central airway (19 masses adjacent to the trachea,
FIGURE 1. A, Chest CT revealed
an abnormal shadow 30 mm in di-
ameter located adjacent to the right
B8 bronchus. B, Segmental pulmo-
nary artery running beside the tu-
mor close to the right B8 bronchus
on mediastinal window. C, Doppler
mode EBUS image showed the seg-
mental pulmonary artery inside of
the tumor. D, EBUS-TBNA of the
lesion showing the needle within
the tumor. E, Cytologic examination
revealed adenocarcinoma from
known colon cancer. F, Histologic
diagnosis was metastatic lung tu-
mor from colon cancer.
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5 adjacent to the intermediate bronchus, 3 adjacent to the
right lobar bronchus, 6 adjacent to the right segmental bron-
chus, and 2 adjacent to the left segmental bronchus) were
evaluated in this study. There were 29 male and the average
age was 63.2 years (range, 37–86). Conventional transbron-
chial biopsies were performed in 26 of 35 patients (74.3%)
before EBUS-TBNA and were nondiagnostic in all 26 pa-
tients. The other 9 cases were judged to be nonaccessible by
conventional transbronchial biopsies based on CT and bron-
choscopic findings.
EBUS-TBNA Results
The size of pulmonary lesions on CT varied from 10 to
70 mm in short axis with an average of 30.0 mm (19 lesions
were less than 3 cm and 16 were larger than 3 cm). Histologic
specimens were available in 23 of 35 patients (65.7%).
Pathologic diagnosis was achieved in 33 patients (94.3%, 10
patients by cytology alone, 23 patients by both cytology and
histology) and malignant cells were detected in 32 patients.
Two false negative patients were diagnosed based on cytol-
ogy alone. The final diagnosis was lung cancer in 26 patients
(1 small cell lung cancer, 25 non-small cell lung cancer),
metastatic lung tumors in five, BALT lymphoma in one and
focal fibrosis in one. Out of the 32 cases of malignancy,
TBNA positive results were confirmed by thoracotomy in 9
cases, thoracoscopy in one case and course observation in 22
cases. Nonsurgical treatment was performed in course obser-
vation cases. EBUS-TBNA was nondiagnostic in 2 patients:
one patient had a tumor located adjacent to the trachea which
was diagnosed as adenocarcinoma by thoracotomy. The other
was a metastatic lung tumor from renal cell carcinoma diag-
nosed also by thoracotomy. The sensitivity, specificity, neg-
ative predictive value, positive predictive value, and diagnostic
accuracy rate of EBUS-TBNA for the diagnosis of intrapulmo-
nary masses was 94.1%, 100%, 33.3%, 100%, and 94.3%,
respectively (Table 1). We did not experience any complications
related to EBUS-TBNA.
DISCUSSION
EBUS-TBNA is a real-time transbronchial needle as-
piration technique that was developed mainly for the assess-
ment of mediastinal lymph nodes. Although most of the
mediastinal and hilar lymph nodes can be assessed (stations
2, 4, 7, 10, 11, 12), because of the size of the CP-EBUS there
is a limit in the reach. From our experience, CP-EBUS can
access down to the segmental bronchus in most of the cases.
Past reports on EBUS-TBNA have focused on sampling of
mediastinal and hilar lymph nodes.10–14 From our experience
in over 1600 procedures, we have come across cases, where
CP-EBUS was effective for the diagnosis of intrapulmonary
lesions located adjacent to the central airway. This study was
a retrospective chart review of such cases in our practice.
Under real-time ultrasound control and by using the Doppler
mode, vessels usually running along the central airway can be
avoided during EBUS-TBNA. This resulted in the safety and
high yield in this case series with the sensitivity and diag-
nostic accuracy rate of 94.1% and 94.3%, respectively. We
did not encounter any complications related to the procedure.
Conventional bronchoscopic diagnostic modalities in-
cluding transbronchial biopsy, transbronchial needle aspira-
tion, and brushing are used for the diagnosis of unknown
pulmonary nodules.16,17 Fluoroscopy guidance increases the
sensitivity of bronchoscopic biopsies.17–19 The reported over-
all sensitivity in the diagnosis of peripheral lesion under
fluoroscopy guidance is 78% and the sensitivity tends to
improve when the bronchus is extended to the tumor. On the
other hand, the sensitivity of conventional TBNA is 65%.17
To further increase the yield of transbronchial biopsy, new
diagnostic modalities such as CT guided bronchoscopy, virtual
bronchoscopic navigation, electromagnetic navigation bron-
choscopy, and endobronchial ultrasound with guide sheath
(EBUS-GS) have been introduced.1–9 However, there are limi-
tations in each technique. CT guided bronchoscopy is a real time
procedure, but is costly, requires the CT suite and, hence there
are only limited reports on its effectiveness.1 Virtual broncho-
scopic navigation has been reported to increase the yield for
diagnosis of peripheral nodules from specialized centers in
Japan,2,3 but is still not available in the market. It uses virtual
images reconstructed from CT obtained before the procedure.
Therefore it is not a real-time procedure. Electromagnetic nav-
igation bronchoscopy also uses CT images for guidance.4,5
EBUS-GS uses the radial probe EBUS in combination with the
guide sheath for biopsy of peripheral lesions.6,7 Its application is
peripheral lesions and due to the nature of the sheath and probe,
EBUS-GS cannot be used for the diagnosis of centrally located
tumors. EBUS-TBNA can be performed under real-time ultra-
sound control without the use of the CT or other costly devices.
CT guided transthoracic needle aspiration is the most
commonly used modality by interventional radiologists and
pulmonologists for tissue diagnosis of pulmonary nodules
when the lesion is not visible on bronchoscopy. The reported
yield is high and thus being performed routinely.17,20,21 How-
ever, compared with transbronchial biopsies, complications
including pneumothorax are seen at a fairly high rate21,22 with
possible tumor seeding in some cases.23,24 The yield is lower
for centrally located tumors compared with peripheral le-
sions.25,26 A bronchoscopic real-time procedure that can ac-
cess centrally located tumors not visible on bronchoscopy
(EBUS-TBNA) would solve most of these problems.
It should be noted that there are several limitations that
apply to this case study. Firstly, this was a retrospective case
study looking at patients with centrally located lesions with
no bronchoscopic visible lesions. This constitutes only a part
of the population of patients with suspected lung cancer.
TABLE 1. Comparison of EBUS-TBNA Results of Unknown




Malignant 32 2 34
Benign 0 1 1
Total 32 3 35
The sensitivity, specificity, and diagnostic accuracy rate of EBUS-TBNA for
diagnosis of intrapulmonary lesions was 94.1%, 100%, and 94.3%, respectively.
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EBUS-TBNA cannot be used for peripheral lesions that are
beyond the reach of the CP-EBUS. Therefore, the results
cannot be directly compared with other modalities. Secondly,
patients enrolled had a very high suspicion of lung cancer.
This is one of the reasons why the negative predictive value
(33.3%) was lower than what has been previously reported.
Nevertheless, EBUS-TBNA may be used as an alternative to
the more invasive CT guided needle aspiration for centrally
located tumors. It should be noted that it is complementary to
other diagnostic modalities.
In conclusion, EBUS-TBNA is a real-time bronchoscopic
procedure that can be used for the diagnosis of centrally located
lesions not visible on bronchoscopy with a high yield. It is a
minimal invasive procedure that can be performed safely in an
outpatient setting by bronchoscopists.
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